Ownership
Private
Therapeutic Areas
GastroenterologyPulmonologyDermatologyOtherInfectious Diseases
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeVitamin/mineral supplementTopical formulationOral rinse solutionAntiseptic solution

Arcadia Consumer Healthcare General Information

Arcadia Consumer Healthcare markets a portfolio of established, clinically proven over-the-counter medicines and premium vitamin/nutritional supplements. Its flagship brands are widely distributed in major retail outlets across the U.S. The company has grown through both organic brand development and strategic acquisitions, including recent additions such as Naturelo vitamins and CloSYS oral care. No clinical trial data typical of prescription drug development applies; all products are commercial-stage consumer health or wellness solutions.

Contact Information

Website
Primary Industry
Food & Nutrition
Corporate Office
Bridgewater, New Jersey
United States

Drug Pipeline

Nizoral
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Arcadia Consumer Healthcare's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Arcadia Consumer Healthcare Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Arcadia Consumer Healthcare's complete valuation and funding history, request access »

Arcadia Consumer Healthcare Financial Metrics